Receipt of brachytherapy is an independent predictor of survival in glioblastoma in the Surveillance, Epidemiology, and End Results database.

Jiri BartekAli A AlattarSanjay DhawanJun MaTomoyuki KogaPeter NakajiKathryn E DusenberyClark C Chen

Published in: Journal of neuro-oncology (2019)

Our SEER analysis indicates that brachytherapy is associated with improved survival in glioblastoma after controlling for age, tumor size/location, extent of resection, chemotherapy, and external beam radiation.

Keyphrases

high dose
locally advanced
radiation therapy
free survival
rectal cancer
risk factors
squamous cell carcinoma
data analysis